Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models-Reference-Cited by-同舟云学术

Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models

Published:2024-09 Issue:3 Volume:35 Page:102251
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

McConnell Erin M.^ORCID,Chan Dennis,Ventura Katelyn,Callahan Joshua P.,Harris Kathryn,Hunt Vernon H.,Boisjoli Spencer,Knight Daniel,Monk Evan T.,Holahan Matthew R.,DeRosa Maria C.^ORCID

Funder

Michael J. Fox Foundation for Parkinson's Research

Canadian Institutes of Health Research

Carleton University

University of Ottawa

University of Calgary

Natural Sciences and Engineering Research Council of Canada

Publisher

Elsevier BV

Reference61 articles.

1. The burden of Parkinson’s disease: a worldwide perspective;Rocca;Lancet Neurol.,2018

2. Motor symptoms in Parkinson’s disease: A unified framework;Moustafa;Neurosci. Biobehav. Rev.,2016

3. Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease;Cha;J. Mov. Disord.,2023

4. Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson’s Disease;Kumari;ACS Chem. Neurosci.,2023

5. The many faces of α-synuclein: from structure and toxicity to therapeutic target;Lashuel;Nat. Rev. Neurosci.,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking bad aggregates: How a DNA aptamer cleans up Parkinson’s disease;Molecular Therapy - Nucleic Acids;2024-09